2024 |
Oncolytics Biotech, Inc.
|
Chairman of the Board and Interim Chief Executive |
134.6 K |
- |
2023 |
Altimmune Inc
|
Independent Director |
108.7 K |
-63.6 % |
2022 |
Altimmune Inc
|
Independent Director |
298.6 K |
-16.9 % |
2022 |
Oncolytics Biotech, Inc.
|
Chairman of the Board |
150.5 K |
-19.2 % |
2021 |
Altimmune Inc
|
Independent Director |
359.1 K |
-21.4 % |
2021 |
Oncolytics Biotech, Inc.
|
Chairman of the Board |
186.2 K |
16.7 % |
2020 |
Altimmune Inc
|
Independent Director |
456.9 K |
391.7 % |
2020 |
Oncolytics Biotech, Inc.
|
Chairman of the Board |
159.6 K |
20.7 % |
2019 |
Oncolytics Biotech, Inc.
|
Chairman of the Board |
132.2 K |
-9.9 % |
2019 |
Altimmune Inc
|
Independent Director |
92.9 K |
406.9 % |
2018 |
Oncolytics Biotech, Inc.
|
Chairman of the Board |
146.8 K |
-12.7 % |
2018 |
Altimmune Inc
|
Independent Director |
18.3 K |
- |
2017 |
Oncolytics Biotech, Inc.
|
Chairman of the Board |
168.0 K |
33.2 % |
2017 |
Altimmune Inc
|
Independent Director |
- |
- |
2016 |
Oncolytics Biotech, Inc.
|
Chairman of the Board |
126.1 K |
84.1 % |
2015 |
Oncolytics Biotech, Inc.
|
Co-Chairman of the Board |
68.5 K |
83.9 % |
2014 |
Oncolytics Biotech, Inc.
|
Independent Director |
37.3 K |
-62.7 % |
2013 |
Oncolytics Biotech, Inc.
|
Independent Director |
99.8 K |
- |